Dell Technologies (NYSE: DELL) reported fourth quarter 2020 adjusted earnings of $2.00 per share. The company reported GAAP revenue of $24 billion and non-GAAP revenue of $24.1 billion. The market had expected Dell to post earnings of $2.02 per share on revenue of $24 billion. DELL stock dropped about 5% during the extended-trading hours.
DELL stock tumbled to a new 52-week low ($42.90) in today’s regular trading session as the tech giant Microsoft (NASDAQ: MSFT) sent a caution to the Wall Street that its PC business might not meet the guidance due to the impact of coronavirus outbreak.
On a GAAP basis, the company’s net income stood at $416 million or $0.54 per share for the quarter ended January 31, 2020. This compares to a loss of $287 million for the fourth quarter ended February 1, 2019.
Client Solutions Group revenue grew 8% year-over-year to $11.8 billion in the recently ended quarter. Dell shipped a record 46.5 million units during the 2019 calendar year. Infrastructure Solutions Group revenue decreased 11% to $8.8 billion.
Dell Technologies also announced a new share repurchase program of up to $1 billion over the next 24 months, effective immediately.
Also Read: Trade Desk (TTD) tops Q4 2019 earnings and revenue targets; guides above view
On February 18, Dell sold its RSA security business to private equity firm Symphony Technology Group for $2.075 billion. This transaction is expected to close in the next six to nine months.
Dell’s subsidiary VMware (NYSE: VMW) also reported its Q4 results today. VMware posted adjusted earnings of $2.05 per share on revenue of $3.07 billion. VMW stock was down about 5% in the extended trading hours.
Shares of Dell have retreated 18% in the last five trading days and 9% in the past 30 days.
Most Popular
United Parcel Service (UPS) seems on track to regain lost strength
Cargo giant United Parcel Service, Inc. (NYSE: UPS) ended fiscal 2023 on a weak note, reporting lower revenues and profit for the fourth quarter. The company experienced a slowdown post-pandemic
IPO Alert: What to look for when Boundless Bio goes public
Boundless Bio is preparing to debut on the Nasdaq stock market this week, and become the latest addition to the list of biotech firms that have launched IPOs this year.
Nike (NKE) bets on innovation and partnerships to return to high growth
Sneaker giant Nike, Inc. (NYSE: NKE) has been going through a rough patch for some time, with sales coming under pressure from weak demand and rising competition. Post-pandemic, the company
Comments
Comments are closed.